These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9512905

  • 21. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N, Tsuchida T, Tamaki K.
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [Abstract] [Full Text] [Related]

  • 22. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Cytokines in systemic lupus erythematosus].
    Robak E, Sysa-Jedrzejowska A, Robak T.
    Przegl Lek; 1996 Sep; 53(8):623-6. PubMed ID: 8999465
    [Abstract] [Full Text] [Related]

  • 26. Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.
    McKenna RM, Wilkins JA, Warrington RJ.
    J Rheumatol; 1988 Nov; 15(11):1639-42. PubMed ID: 3148712
    [Abstract] [Full Text] [Related]

  • 27. Increased CCR4 expression in active systemic lupus erythematosus.
    Hase K, Tani K, Shimizu T, Ohmoto Y, Matsushima K, Sone S.
    J Leukoc Biol; 2001 Nov; 70(5):749-55. PubMed ID: 11698495
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
    Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-Pérez D, Niño-Moreno P, Valencia-Pacheco G, Abud-Mendoza C, Alcocer-Varela J, González-Amaro R.
    Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219
    [Abstract] [Full Text] [Related]

  • 30. [Effect of corticosteroids on the balance of Th cytokines in patients with systemic lupus erythematosus].
    Xie HF, Li J, Shi W.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):533-5. PubMed ID: 12658932
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
    Vallin H, Perers A, Alm GV, Rönnblom L.
    J Immunol; 1999 Dec 01; 163(11):6306-13. PubMed ID: 10570325
    [Abstract] [Full Text] [Related]

  • 33. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
    Kanda N, Watanabe S.
    J Allergy Clin Immunol; 2000 Mar 01; 105(3):532-40. PubMed ID: 10719304
    [Abstract] [Full Text] [Related]

  • 34. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH, Anderson M, Le E, La Cava A.
    Arthritis Rheum; 2008 Aug 01; 58(8):2488-97. PubMed ID: 18668553
    [Abstract] [Full Text] [Related]

  • 35. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
    Narumi S, Takeuchi T, Kobayashi Y, Konishi K.
    Cytokine; 2000 Oct 01; 12(10):1561-5. PubMed ID: 11023674
    [Abstract] [Full Text] [Related]

  • 36. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P, Gómez J, Prado C, Gutiérrez C, Suárez A.
    J Rheumatol; 2008 Aug 01; 35(8):1559-66. PubMed ID: 18597405
    [Abstract] [Full Text] [Related]

  • 37. Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide.
    Curtin NM, Boyle NT, Mills KH, Connor TJ.
    Brain Behav Immun; 2009 May 01; 23(4):535-47. PubMed ID: 19217938
    [Abstract] [Full Text] [Related]

  • 38. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr 01; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 39. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I.
    J Autoimmun; 1998 Oct 01; 11(5):503-8. PubMed ID: 9802936
    [Abstract] [Full Text] [Related]

  • 40. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul 01; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.